Pazopanib in pretreated advanced neuroendocrine tumors: a phase II, open-label trial of the Spanish Task Force Group for Neuroendocrine Tumors (GETNE)
2015 · Annals of Oncology · 155 citations
https://doi.org/10.1093/annonc/mdv252
P
P. Escudero
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
224
Papers
4.1K
Citations
27
h-index
61
i10-index
P. Escudero is an academic researcher. The author has contributed to research in topics: Colorectal Cancer Treatments and Studies & Gastric Cancer Management and Outcomes & Cancer Treatment and Pharmacology. The author has an h-index of 27, co-authored 191 publications.
Papers by this author
worksXELOX (capecitabine plus oxaliplatin) as first-line treatment for elderly patients over 70 years of age with advanced colorectal cancer
2006 · British Journal of Cancer · 113 citations
https://doi.org/10.1038/sj.bjc.6603047
A randomized phase II study of capecitabine-based chemoradiation with or without bevacizumab in resectable locally advanced rectal cancer: clinical and biological features
2015 · BMC Cancer · 49 citations
https://doi.org/10.1186/s12885-015-1053-z
First-line bevacizumab and capecitabine–oxaliplatin in elderly patients with mCRC: GEMCAD phase II BECOX study
2014 · British Journal of Cancer · 32 citations
https://doi.org/10.1038/bjc.2014.346
Irinotecan plus raltitrexed as first-line treatment in advanced colorectal cancer: a phase II study
2004 · British Journal of Cancer · 24 citations
https://doi.org/10.1038/sj.bjc.6601713
Clinical impact of circulating tumor RAS and BRAF mutation dynamics in metastatic colorectal cancer patients treated with first-line chemotherapy plus anti-EGFR therapy: Combined analysis of two prospective clinical trials
2018 · Annals of Oncology · 0 citations
https://doi.org/10.1093/annonc/mdy281.091
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat